Literature DB >> 21964186

The earliest tau dysfunction in Alzheimer's disease? Tau phosphorylated at s422 as a toxic seed.

Kellen Voss1, John Koren, Chad A Dickey.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21964186      PMCID： PMC3204013          DOI： 10.1016/j.ajpath.2011.08.020

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  39 in total

1.  Reduction of soluble Abeta and tau, but not soluble Abeta alone, ameliorates cognitive decline in transgenic mice with plaques and tangles.

Authors:  Salvatore Oddo; Vitaly Vasilevko; Antonella Caccamo; Masashi Kitazawa; David H Cribbs; Frank M LaFerla
Journal:  J Biol Chem       Date:  2006-10-20       Impact factor: 5.157

2.  Plaques, tangles and dementia. A quantitative study.

Authors:  G K Wilcock; M M Esiri
Journal:  J Neurol Sci       Date:  1982-11       Impact factor: 3.181

3.  Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer's disease: potential significance for tau protein phosphorylation.

Authors:  J G Sheng; R A Jones; X Q Zhou; J M McGinness; L J Van Eldik; R E Mrak; W S Griffin
Journal:  Neurochem Int       Date:  2001 Nov-Dec       Impact factor: 3.921

4.  A caspase cleaved form of tau is preferentially degraded through the autophagy pathway.

Authors:  Philip J Dolan; Gail V W Johnson
Journal:  J Biol Chem       Date:  2010-05-13       Impact factor: 5.157

5.  Pseudophosphorylation of tau at serine 422 inhibits caspase cleavage: in vitro evidence and implications for tangle formation in vivo.

Authors:  Angela L Guillozet-Bongaarts; Michael E Cahill; Vincent L Cryns; Matthew R Reynolds; Robert W Berry; Lester I Binder
Journal:  J Neurochem       Date:  2006-04-05       Impact factor: 5.372

6.  Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease.

Authors:  X Zhu; C A Rottkamp; H Boux; A Takeda; G Perry; M A Smith
Journal:  J Neuropathol Exp Neurol       Date:  2000-10       Impact factor: 3.685

7.  Phosphorylation and cleavage of tau in non-AD tauopathies.

Authors:  Angela L Guillozet-Bongaarts; Kelly E Glajch; Emilie G Libson; Michael E Cahill; Eileen Bigio; Robert W Berry; Lester I Binder
Journal:  Acta Neuropathol       Date:  2007-03-15       Impact factor: 17.088

8.  Phosphorylation of Tau at S422 is enhanced by Abeta in TauPS2APP triple transgenic mice.

Authors:  Fiona Grueninger; Bernd Bohrmann; Christian Czech; Theresa Maria Ballard; Johann R Frey; Claudia Weidensteiner; Markus von Kienlin; Laurence Ozmen
Journal:  Neurobiol Dis       Date:  2009-09-23       Impact factor: 5.996

9.  Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology.

Authors:  Robert A Rissman; Wayne W Poon; Mathew Blurton-Jones; Salvatore Oddo; Reidun Torp; Michael P Vitek; Frank M LaFerla; Troy T Rohn; Carl W Cotman
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

10.  Sequential phosphorylation of tau protein by cAMP-dependent protein kinase and SAPK4/p38delta or JNK2 in the presence of heparin generates the AT100 epitope.

Authors:  Hirotaka Yoshida; Michel Goedert
Journal:  J Neurochem       Date:  2006-10       Impact factor: 5.372
View more
  4 in total

1.  Co-Localization of Glia Maturation Factor with NLRP3 Inflammasome and Autophagosome Markers in Human Alzheimer's Disease Brain.

Authors:  Mohammad Ejaz Ahmed; Shankar Iyer; Ramasamy Thangavel; Duraisamy Kempuraj; Govindhasamy Pushpavathi Selvakumar; Sudhanshu P Raikwar; Smita Zaheer; Asgar Zaheer
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 2.  Neuroprotective Approach of Anti-Cancer Microtubule Stabilizers Against Tauopathy Associated Dementia: Current Status of Clinical and Preclinical Findings.

Authors:  Pallavi Duggal; Sidharth Mehan
Journal:  J Alzheimers Dis Rep       Date:  2019-07-02

3.  Panax notoginsenoside Rb1 ameliorates Alzheimer's disease by upregulating brain-derived neurotrophic factor and downregulating Tau protein expression.

Authors:  Yu Wang; Yu Feng; Qunying Fu; Lei Li
Journal:  Exp Ther Med       Date:  2013-07-11       Impact factor: 2.447

4.  Autophagic and lysosomal defects in human tauopathies: analysis of post-mortem brain from patients with familial Alzheimer disease, corticobasal degeneration and progressive supranuclear palsy.

Authors:  Antonio Piras; Ludovic Collin; Fiona Grüninger; Caroline Graff; Annica Rönnbäck
Journal:  Acta Neuropathol Commun       Date:  2016-03-02       Impact factor: 7.801
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.